Escherichia coli is a well-established, and popular host for heterologous expression of proteins. 24 unsatisfying. Our new approach, adjusting the tRNA pool by co-expressing extra copies of rare 46 tRNA genes with ribosomal RNA genes, does not affect normal cell physiology, and seems to be 47
The preference in the choice of synonymous codons (codon bias), however, might differ for the 25 host and the original source of the recombinant protein, constituting a potential bottleneck in 26 production. Codon choice affects the efficiency of translation by a complex and poorly 27 understood mechanism. The availability of certain tRNA species is one of the factors that may 28 curtail the capacity of translation. 29
Here we provide a tRNA-overexpressing strategy that allows the resolution of the codon bias, and 30 boosts the translational capacity of the popular host BL21(DE3) when rare codons are 31 encountered. In BL21(DE3)-derived strain, called SixPack, copies of the genes corresponding to 32 the six least abundant tRNA species have been assembled in a synthetic fragment and inserted 33 into a ribosomal RNA operon. This arrangement, while not interfering with the growth properties 34 of the new strain, allows dynamic control of the transcription of the extra tRNA genes, providing 35 significantly elevated levels of the rare tRNAs in exponential growth phase. 36
Results from expression assays of a panel of heterologous proteins of diverse origin and codon 37 composition showed that the performance of SixPack surpassed that of the parental BL21(DE3) 38 or a related strain equipped with a rare tRNA-expressing plasmid. 39 40 Importance 41 42 Codon composition not fitting the codon bias of the expression host frequently compromises the 43 efficient production of foreign proteins in E. coli. Various attempts to remedy the problem (codon 44 optimization by gene synthesis, expression of rare tRNAs from a plasmid) proved to be 45 a superior solution in terms of simplicity, cost, and yield. 48 49 Introduction 50 51 E. coli is by far the most widely used host organism for biopharmaceutical heterologous 52 production of recombinant proteins. This expression platform is favored for its simplicity, speed, 53 and low cost. The codon bias discrepancy, however, can seriously hinder protein expression in E. 54 coli (1) (2) (3) (4) (5) . Choice in the usage of synonymous codons can be different in various organisms, and 55 this bias has been shown to correlate with the relative and absolute quantities of individual tRNAs 56 (6,7). Heterologous expression of a protein with a high ratio of codons occurring infrequently in 57 E. coli might deplete the corresponding tRNA species, leading to translational frameshifting, 58 codon skipping, misincorporations, and protein truncations (8). Ultimately, the codon bias 59 seriously limits the use of E. coli as an expression platform. 60 61 To overcome this problem, codon optimization or rare tRNA overexpression strategies have been 62 applied, with limited success. On one hand, synthesis of the recombinant protein encoding gene 63
with an E. coli codon preference is labor-intensive and expensive. Moreover, replacing rare 64 codons with frequent ones does not necessarily lead to increased yield in protein synthesis. Codon 65 choice might affect expression, solubility, and folding of a protein (9-12); and rare codons can, 66 paradoxically, enhance the translation of a gene via reducing the mRNA secondary structure 67 (7, 13, 14) . Additionally, codon optimization by gene synthesis is not feasible when testing gene 68 libraries. On the other hand, attempts to overexpress rare tRNA species by cloning extra copies of 69 4 the corresponding tRNA encoding genes into a plasmid have their drawbacks as well. In such 70 commercially available hosts, maintenance of the tRNA-expressing plasmid requires the addition 71 of extra antibiotics (usually the protein synthesis inhibitor chloramphenicol); moreover, the 72 recombinant protein-encoding expression plasmid must belong to a different complementation 73 group. Using two antibiotics and/or permanently altering the balance of the various tRNA species 74
can have a fitness cost on the host, eventually resulting in a low success rate in applications 75 (10,15). 76
77
We sought to resolve the codon bias problem by expressing rare tRNAs in a more dynamic 78 fashion. We hypothesized that inserting extra copies of the relevant tRNA genes into a ribosomal 79 RNA (rrn) operon would harmonize their expression with the translational activity and would 80 provide enhanced levels of rare tRNAs according to the actual needs. rrn operons have key roles 81 in bacterial physiology and economy. Synthesis of rRNA quickly reacts to environmental 82 conditions, determining ribosome availability via regulating the expression of ribosomal proteins 83 by a translational feedback mechanism (16). In E. coli, there are seven nearly identical copies of 84 rRNA operons. Synthesis of rRNA is driven by the strongest promoters found in the genome 85 (17), and the rate of transcription can change more than an order of magnitude between poor and 86 rich nutrient conditions (18). While most of the tRNA genes are scattered around the 87 chromosome, all rRNA operons carry certain (but not any of the rare) tRNA genes as well, co-88 transcribed with the rRNA genes. 89
90
We inserted extra copies of the six tRNA genes (argX, glyT, leuW, proL, argU, and ileX) 91 corresponding to the minor codons of E. coli (CGG, GGA, CUA, CCC, AGA/AGG, and AUA, 92 respectively) into one of the ribosomal RNA operons (rrnD) of BL21(DE3), the widely used E. 93 5 coli expression host. We demonstrated that expression of these tRNA genes varies with growth 94 rate and shows a marked increase compared to the unmodified host. By testing the expression of a 95 panel of recombinant proteins with a high ratio of rare codons in their genes, we showed that, in 96 most cases, the modified strain named SixPack performs better and shows significantly enhanced 97 expression of the heterologous proteins in classical IPTG-induction as well as in an auto- Hypothetically, cloning extra copies of the genes corresponding to rare tRNAs into a rrn operon 106 allows their controlled expression, as the activity of the operon is tightly regulated by nutrient 107 availability and other physiological conditions (19) . This might ensure that expression of the rare 108 tRNAs does not cause a permanent extra burden for the cell. 109
110
The genes encoding for the six least abundant tRNA species were combined in a single, synthetic 111 DNA fragment. The original copies of these genes are either single genes whose expression is 112 controlled by their own promoter (proL, argU, or ileX), or are parts of polycistronic operons 113 (argX, glyT, or leuW) ( Fig. S1 ). Since the process of maturation of the primary transcripts of 114 tRNA genes is not thoroughly understood, the nucleotide sequences surrounding the genes in the 115 synthetic fragment were designed to mimic the natural tRNA operons. The intergenic and 116 flanking regions of the argX-glyT-leuW-proL segment were essentially identical to those of the 117 6 natural argX-hisR-leuT-proM polycistronic operon. For argU and ileX, exact copies of the genes 118 and their flanking sequences were fused to the 3' end of the segment (Fig. S2) . 119 120 For the genomic insertion site rrnD, one of the seven rrn operons was selected. Although the 121 structure, sequence, and activity of the rrn operons of E. coli are very similar, the 3' end of rrnD 122 (containing trhV and rrfF) is unique, allowing specific targeting of the locus (17). 123
124
The 1207-base synthetic operon carrying the six tRNA genes was engineered into the 3' region of 125 rrnD (Fig. 1 ) by a multistep process using RED recombineering, followed by elimination of the 126 markers via CRISPR-Cas9-stimulated homologous recombination ( Fig. S3 ), resulting in strain 127
SixPack. 128 129

Growth properties of SixPack and control strains 130
Apparently, insertion of the extra tRNA genes into rrnD did not disturb the homeostasis of the 131 cell. The growth parameters of SixPack were identical to those of the parental BL21(DE3) in both 132 LB and AIM (auto-induction medium). Noticeably, the commercially available 133 Rosetta2(DE3)pLysS strain had a longer lag phase, lower growth rate, and lower maximum OD 134 in both media, presumably owing to the burden of maintaining the plasmid and the presence of 135 the antibiotic chloramphenicol in the media ( Fig. 2 and Table S1 ). 136 137
Elevated expression of rare tRNAs 138
Expression of the six rare tRNA genes was measured by qRT-PCR on first-strand cDNA 139 generated from total RNA isolated from cultures of BL21(DE3) and SixPack in the exponential 140 phase (OD600 = 0.45) and in the early stationary phase (OD600 = 4.5). Primers were designed to 7 amplify both the unprocessed and the matured forms of the various tRNA species. In the case of 142 SixPack, the measured rare tRNAs represented transcripts originating both from their original 143 genomic copies and from the newly inserted fragment in rrnD. The rare tRNA ratios were 144 normalized with the ratios of three control (abundant) tRNA species. 145 146 Compared to parental BL21(DE3), SixPack showed elevated expression of the six rare tRNAs. 147
The difference was more pronounced in the exponential phase (1.4-to 3.8-fold) than in the 148 stationary phase (0.8-to 3.0-fold) ( Fig. 3) . 149 150 Despite being on the same cistron and transcribed together, increases in the expression levels of 151 the extra tRNA genes were diverse (proL showing the highest and glyT the lowest increase). This 152 might be due to several factors, including tRNA processing, stability, regulation, and diverse 153 expression levels of the original genomic copies. 154 155
Individual impact of elevated levels of the rare tRNAs on protein expression 156
The functional effect of the increased levels of rare tRNAs was first tested separately for each 157 tRNA species. To magnify the effect of rare tRNAs, we constructed IPTG-inducible, pETDuet-1-158 based (Novagen) test plasmids expressing modified versions of the GFP gene under the 159 regulation of the T7 promoter. GFP genes carrying runs of rare codons corresponded to each of 160 the six extra tRNA genes (one GFP version corresponding to proL, ileX, argX, glyT, and leuW 161 each, and two GFP versions for argU, as it relates to both AGA and AGG codons). The tandem 162 rare codons (3 or 5 copies) were inserted into the GFP gene immediately after the beginning ATG 163 codon. Expressions of the modified GFPs were detected by fluorescence measurements and 164 visualized by denaturing polyacrylamide gel electrophoresis (SDS-PAGE). 165 8 166 IPTG-(or lactose-) induced expression of the GFP and its variants with rare codons had a 167 negative but diverse impact on the growth of the strains. In LB medium, SixPack and BL21(DE3) 168 usually showed similar growth patterns, and in most cases displayed higher growth parameters 169 than Rosetta2(DE3)pLysS. In AIM, peculiarly, Rosetta2(DE3)pLysS reached the highest 170 maximal optical density when GFP variants with rare codons were expressed ( Fig. S4 and S5) . The growth curves of IPTG-(or lactose-) induced cultures seemed to be quite diverse in LB (Fig. 192 S8), but rather uniform in AIM (Fig. S9 ). Production of the specific proteins was visualized by 193 using Coomassie-stained gels and Western blotting (Fig. 5 ). In most cases, SixPack proved to be 194 the best producer. This was especially evident when the ratio of rare codons was higher than 8% 195 (and the ratio of tandems was also high), as in the cases of HumdCas9 (dCas9 optimized to 196 human codon preference), HumdCas9-GFP fusion, and Pfu DNA polymerase. In the case of 197 EFT1, the ratio was only 4.3% (35 AGA and 2 CTA codons); but SixPack still produced the 198 highest amount of this protein. It is conceivable that the translation efficiency is influenced not 199 only by the total amount of rare codons, but also by the occurrence of tandem situations, the 200 location of rare codons in the gene (e.g., close or far from the start site), and the ratios of the 201 different rare codon species (3). In other cases (Asl, dCas9, Flfl, and HPV16 L2), when the rare 202 codon ratio was below 8%, production by SixPack was similar to that of BL21(DE3) in LB and 203 similar to or better than that in AIM. In all cases, the performance of Rosetta2(DE3)pLysS lagged 204 behind that of SixPack (especially evidently in AIM) or was similar at most ( Fig. 6) . To create the SixPack strain, BL21(DE3) was modified by inserting extra copies of six rare tRNA 278 genes (argU, argX, glyT, leuW, ileX, and proL) into its rrnD operon (Fig. 1) . These tRNAs 279 recognize the same rare codons as the tRNAs expressed from the pLysSRARE2 plasmid (AGG is 280 recognized by argX and argW in Rosetta2(DE3)pLysS, but only by argX in SixPack). 281 282
Genomic construct 283 13
The rare tRNA genes were cloned into pSG76A (replicating by R6K ori) in three pieces. The first 284 part (synthesized by Thermo Fisher Scientific GENEART GmbH; Germany) contained the argX, 285 glyT, leuW, and proL tRNA genes. The structure of this DNA fragment was based on the 286 polycistronic operon of E. coli coding for argX, hisR, leuT, and proM tRNA genes; we replaced 287 the hisR, leuT, and proM genes with glyT, leuW, and proL rare tRNA genes, but kept argX and 288 the original intergenic regions. The second and third pieces coding for argU and ileX, 289 respectively, were directly amplified from the E. coli genome with their own intergenic regions 290 ( Fig. S1 and S2) . 291
The plasmid carrying the six tRNA genes was linearized by PCR using overhanging primers 292 containing homologous regions (50-or 100-nt) with the target site (unique sequence of the 3' end 293 of rrnD), and transformed into BL21(DE3) in the presence of RED recombinase (27). After 294 successful recombination into the genome, the CRISPR-Cas9 system was used to introduce a 295 double-strand brake in the ampicillin resistance gene on the insert (28). The cells' own RecA 296 system repaired the cleavage by homologous recombination using the 47-nt box on the plasmid 297 homologous to the adjacent rrnD sequence downstream from the site of insertion (29) ( Fig. S3  298 and S10). 299 300
Expression plasmids 301
The coding sequences of different test proteins were cloned into pETDuet-1 (Novagen). A list of 302 these genes and the cloning sites is given in Table S3 . 303
The GFP-encoding gene was amplified from pCA24N (the cloning plasmid of the ASKA 304 collection; 30), and subcloned into pETDuet-1. GFP gene variants containing runs of rare codons 305 were created by PCR using pETDUET/GFP as a template. 306
14
The coding DNA sequence of asterless (Asl) was subcloned from the GH02902 Drosophila Gold 307 cDNA clone into pETDuet-1 following standard procedures. 308
Cloning of Flf1 into pETDuet-1 has been described elsewhere (31). 309 dCas9 was cloned from the pdCas9 plasmid # 46569 from Addgene (32). 310
The HumdCas9 gene was amplified from pMLM3705 plasmid # 47754 from Addgene (33). (Table S4 ). After dilution with 20 μl of water, 1 μl of the diluted reaction mixture 326 was used as a template in qRT-PCR with 10 μl of qPCRBIO SyGreen Mix (PCR Biosystems) and 327 1 μl of gene-specific primer mix, according to the following protocol: 10 min at 95°C followed 328 by 40 cycles of 95°C for 25 sec, 60°C for 25 sec, and 72°C for 15 sec. The CRISPR-Cas9 targeting sequence (C) was cloned into pCRISPR plasmid (Addgene #42875) 643 and used as crRNA targeting the Cas9 protein (expressed from Addgene #42876) to the 644 ampicillin resistance gene of pSG76A. 645 646 Table S1 . Growth parameters of BL21(DE3) (marked BL), SixPack, and Rosetta2(DE3)pLysS 647 (marked R) strains grown in LB and AIM. 648 649 30 Table S2 . Size and rare codon composition of the ORFs of test proteins. SixPack showed more 650 effective protein production than the parental strain BL21(DE3) when the ratio of rare codons 651 was about 8% or more (labeled with circles). The efficient translation of EFT1 by SixPack might 652 be due to the extremely high ratio of one rare codon species, AGA (labeled with rectangle). 653 654 Table S3 . List of 16 protein-expressing plasmid (pETDuet-1) constructs and the cloning sites 655 used. 656 657 Table S4 . Primers used for qRT-PCR. argX, glyT, leuW, proL, argU, and ileX correspond to rare; 658 alaU, gltW and proK correspond to abundant (control) tRNA species. 659
